Format

Send to

Choose Destination
J Am Chem Soc. 2014 Jan 8;136(1):52-5. doi: 10.1021/ja410813j. Epub 2013 Dec 17.

Lipoprotein activators stimulate Escherichia coli penicillin-binding proteins by different mechanisms.

Author information

1
Department of Microbiology and Immunobiology, Harvard Medical School , Boston, Massachusetts 02115, United States.

Abstract

In Escherichia coli , the bifunctional penicillin-binding proteins (PBPs), PBP1A and PBP1B, play critical roles in the final stage of peptidoglycan (PG) biosynthesis. These synthetic enzymes each possess a PG glycosyltransferase (PGT) domain and a transpeptidase (TP) domain. Recent genetic experiments have shown that PBP1A and PBP1B each require an outer membrane lipoprotein, LpoA and LpoB, respectively, to function properly in vivo. Here, we use complementary assays to show that LpoA and LpoB each increase the PGT and TP activities of their cognate PBPs, albeit by different mechanisms. LpoA directly increases the rate of the PBP1A TP reaction, which also results in enhanced PGT activity; in contrast, LpoB directly affects PGT domain activity, resulting in enhanced TP activity. These studies demonstrate bidirectional coupling of PGT and TP domain function. Additionally, the transpeptidation assay described here can be applied to study other activators or inhibitors of the TP domain of PBPs, which are validated drug targets.

PMID:
24341982
PMCID:
PMC3961711
DOI:
10.1021/ja410813j
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for American Chemical Society Icon for PubMed Central
Loading ...
Support Center